Search

Search Results

• The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis

  M. Varenna, D. Gatti

  163-171

  https://doi.org/10.4081/reumatismo.2010.163

  1777

  PDF: 1210
• 

  Duration of treatment for osteoporosis

  Luca Idolazzi, A. Fassio, D. Gatti, S. Tamanini, O. Viapiana, M. Rossini, S. Adami

  22-35

  28-03-2013

  https://doi.org/10.4081/reumatismo.2013.22

  3624

  PDF: 1265
• 

  Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature

  M. Varenna, F. Bertoldo, M. Di Monaco, A. Giusti, G. Martini, M. Rossini, On behalf of SIOMMMS, Endorsed by SIR

  143-166

  31-10-2013

  https://doi.org/10.4081/reumatismo.2013.143

  7116

  PDF: 2581
• 

  Denosumab for the treatment of HIV-associated osteoporosis with fractures in a premenopausal woman

  E. Marasco, M. Mussa, F. Motta, F. Bobbio-Pallavicini, R. Maserati, C. Montecucco, L. Bogliolo

  54-58

  19-04-2021

  https://doi.org/10.4081/reumatismo.2021.1358

  5730

  PDF: 882
• 

  Glucocorticoid-induced osteoporosis: 2013 update

  M. Mazzantini, O. Di Munno

  144-152

  28-07-2014

  https://doi.org/10.4081/reumatismo.2014.787

  3605

  PDF: 2233

• Novel genetic mutation associated with hyperphosphatemic familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome treated with denosumab: a case report

  G. Fabbriciani, A. Colombini, C. Messina, G. Adami

  24-06-2024

  https://doi.org/10.4081/reumatismo.2024.1687

  1098

  PDF: 433
• 

  Drug-induced osteonecrosis of the jaw: the state of the art

  A. Fassio, F. Bertoldo, L. Idolazzi, O. Viapiana, M. Rossini, D. Gatti

  9-15

  22-05-2017

  https://doi.org/10.4081/reumatismo.2017.983

  5044

  PDF: 2900
• 

  Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life

  G. Adami, A. Giollo, M. Rossini, G. Orsolini, C. Benini, O. Viapiana, D. Gatti, A. Fassio

  71-74

  23-07-2020

  https://doi.org/10.4081/reumatismo.2020.1267

  1564

  PDF: 1095